Dashboard
Manage Tickers

FLXNFlexion Therapeutics Inc

Nasdaq www.flexiontherapeutics.com


$ 9.19 $ -0.02 (-0.22 %)    

Thursday, 18-Nov-2021 16:05:52 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 9.12
$ 9.17 x 150
$ 9.19 x 100
-- - --
$ 4.30 - $ 13.66
18,723,201
na
458.93M
$ 1.62
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2021 09-30-2021 10-Q
2 08-04-2021 06-30-2021 10-Q
3 05-12-2021 03-31-2021 10-Q
4 03-10-2021 12-31-2020 10-K
5 11-04-2020 09-30-2020 10-Q
6 08-05-2020 06-30-2020 10-Q
7 05-07-2020 03-31-2020 10-Q
8 03-12-2020 12-31-2019 10-K
9 11-07-2019 09-30-2019 10-Q
10 08-06-2019 06-30-2019 10-Q
11 05-08-2019 03-31-2019 10-Q
12 02-28-2019 12-31-2018 10-K
13 11-07-2018 09-30-2018 10-Q
14 08-07-2018 06-30-2018 10-Q
15 05-08-2018 03-31-2018 10-Q
16 03-08-2018 12-31-2017 10-K
17 11-06-2017 09-30-2017 10-Q
18 08-08-2017 06-30-2017 10-Q
19 05-05-2017 03-31-2017 10-Q
20 03-10-2017 12-31-2016 10-K
21 11-07-2016 09-30-2016 10-Q
22 08-03-2016 06-30-2016 10-Q
23 05-12-2016 03-31-2016 10-Q
24 03-11-2016 12-31-2015 10-K
25 11-09-2015 09-30-2015 10-Q
26 08-06-2015 06-30-2015 10-Q
27 05-08-2015 03-31-2015 10-Q
28 03-24-2015 12-31-2014 10-K
29 11-14-2014 09-30-2014 10-Q
30 08-08-2014 06-30-2014 10-Q
31 05-12-2014 03-31-2014 10-Q
32 03-28-2014 12-31-2013 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

benzingas-top-ratings-upgrades-downgrades-for-november-19-2021
Benzinga's Top Ratings Upgrades, Downgrade...
11/19/2021 15:08:55

 

northland-capital-markets-downgrades-flexion-therapeutics-to-market-perform
Northland Capital Markets Downgrades Flexi...
11/19/2021 13:58:36

Northland Capital Markets analyst Carl Byrnes downgrades Flexion Therapeutics (NASDAQ:FLXN) from Outperform to Market Perform.

what-5-analyst-ratings-have-to-say-about-flexion-therapeutics
What 5 Analyst Ratings Have To Say About F...
10/19/2021 16:06:44

Analysts have provided the following ratings for Flexion Therapeutics (NASDAQ:FLXN) within the last quarter:

benzingas-top-ratings-upgrades-downgrades-for-october-19-2021
Benzinga's Top Ratings Upgrades, Downgrade...
10/19/2021 14:02:22

Upgrades

hc-wainwright--co-downgrades-flexion-therapeutics-to-neutral-lowers-price-target-to-10
HC Wainwright & Co. Downgrades Flexion The...
10/19/2021 10:25:58

HC Wainwright & Co. analyst Patrick Trucchio downgrades Flexion Therapeutics (NASDAQ:FLXN) from Buy to Neutral and lower...

analyst-ratings-for-flexion-therapeutics
Analyst Ratings For Flexion Therapeutics
10/12/2021 16:27:55

Over the past 3 months, 4 analysts have published their opinion on Flexion Therapeutics (NASDAQ:FLXN) stock. These analysts ar...

benzingas-top-ratings-upgrades-downgrades-for-october-12-2021
Benzinga's Top Ratings Upgrades, Downgrade...
10/12/2021 14:48:07

Upgrades

the-daily-biotech-pulse-nrx-stitches-covid-19-drug-partnership-protara-gets-nod-for-starting-bladder-cancer-study-igm-moves-beyond-oncology
The Daily Biotech Pulse: NRx Stitches COVI...
10/12/2021 12:13:34

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

10-biggest-price-target-changes-for-tuesday
10 Biggest Price Target Changes For Tuesday
10/12/2021 11:32:05

  Evercore ISI Group raised Lear Corporation (NYSE: LEA) price target from $170 to $220. Lear shares fell 0.3% to close at $...

bmo-capital-downgrades-flexion-therapeutics-to-market-perform-lowers-price-target-to-12
BMO Capital Downgrades Flexion Therapeutic...
10/12/2021 11:26:02

BMO Capital analyst Gary Nachman downgrades Flexion Therapeutics (NASDAQ:FLXN) from Outperform to Market Perform and lowers ...

raymond-james-downgrades-flexion-therapeutics-to-market-perform
Raymond James Downgrades Flexion Therapeut...
10/12/2021 10:19:31

Raymond James analyst Elliot Wilbur downgrades Flexion Therapeutics (NASDAQ:FLXN) from Strong Buy to Market Perform.

credit-suisse-downgrades-flexion-therapeutics-to-neutral-lowers-price-target-to-10
Credit Suisse Downgrades Flexion Therapeut...
10/12/2021 10:17:03

Credit Suisse analyst Judah Frommer downgrades Flexion Therapeutics (NASDAQ:FLXN) from Outperform to Neutral and lowers the ...

46-biggest-movers-from-yesterday
46 Biggest Movers From Yesterday
10/12/2021 09:01:23

Gainers

Core News & Articles
Mid-Afternoon Market Update: Dow Tumbles O...
10/11/2021 19:17:03

Toward the end of trading Monday, the Dow traded down 0.37% to 34,617.17 while the NASDAQ fell 0.05% to 34,617.14. The S&P ...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
10/11/2021 17:21:26

 

Core News & Articles
Mid-Day Market Update: Crude Oil Surges Ov...
10/11/2021 16:13:16

Midway through trading Monday, the Dow traded up 0.50% to 34,920.55 while the NASDAQ rose 0.50% to 34,920.55. The S&P also ...

Core News & Articles
28 Stocks Moving In Monday's Mid-Day Session
10/11/2021 16:04:57

Gainers

pacira-beefs-up-non-opioid-pain-management-via-flexion-acquisition
Pacira Beefs Up Non-Opioid Pain Management...
10/11/2021 12:57:51

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
10/11/2021 12:12:37

Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares moved upwards by 89.3% to $34.53 during Monday's pre-market sessio...

flexion-therapeutics-shares-resume-trading-shares-up-68-for-session
Flexion Therapeutics Shares Resume Trading...
10/11/2021 11:30:50

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION